by Site Strategics | Mar 2, 2020 | News
In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA...
by Site Strategics | Jan 16, 2020 | Insights
BACKGROUND: Central nervous system (CNS) histoplasmosis often goes unrecognized, delaying diagnosis and treatment, resulting in neurologic complications or death. It occurs in 5% to 10% of patients with disseminated histoplasmosis, and despite clinical suspicion of...
by Site Strategics | Oct 1, 2019 | Announcement Archive
Early and accurate diagnosis of coccidioidomycosis, also known as Valley fever, is critical for appropriate disease treatment and management. Current serodiagnosis is based on the detection of patient serum antibodies that react with tube precipitin (TP) and...
by Site Strategics | Oct 1, 2019 | Announcement Archive
We report a case of disseminated histoplasmosis in a renal transplant recipient who presented with a nodular pulmonary lesion and elevated serum and bronchoalveolar lavage (BAL) Aspergillus galatomannan. This almost led to an erroneous diagnosis of invasive...
by Site Strategics | Sep 30, 2019 | Announcement Archive
Dr. Joseph Wheat presenting Thursday, October 3, 2019 at ID Week Session Date: Thursday, October 3, 2019 Session Time: 12:15 PM – 1:30 PM Stop by poster 236 on October 3rd, 12:15PM – 1:30PM, to speak with Dr. Wheat. Event Details: Session Location: Walter E....